Bausch Health Companies Inc

BHC

$7.36

+1.6% last 12 months

Carl Icahn Holding value: $256 Million John Paulson Holding value: $195 Million Ken Griffin Holding value: $45.1 Million Mario Gabelli Holding value: $10.1 Million Howard Marks Holding value: $9.57 Million Jefferies Group Holding value: $3.68 Million Ray Dalio Holding value: $664 Thousand Paul Tudor Jones II Holding value: $126 Thousand Charles Brandes Holding value: $0 Bill Miller Holding value: $0 Steven Cohen Holding value: $0 Jeremy Grantham Holding value: $0 Jim Simons Holding value: $0 Joel Greenblatt Holding value: $0 Jeffrey Ubben Holding value: $0

Market Cap

$2.58 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$5.57 - $10.23

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

-2.68x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $2.58 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $24.2 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $0.00 (0.0%)
1 Year Return Profit or loss of share price change plus dividend yield. +1.6%
52-Week High Highest share price in the last 52 weeks. $10.23
52-Week Low Lowest share price in the last 52 weeks. $5.57
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.0
Outstanding Shares The number of shares the company has issued and are held by stockholders. 361 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 2.05 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. -2.68
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 1.37
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. -$2.64
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 0.32
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company -1.84
Enterprise Value to Revenue Enterprise value divided by revenue 2.84
Enterprise Value to EBIT Enterprise Value divided by EBIT 15.98
Total Debt to Enterprise Value Total debt divided by enterprise value 0.93
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -19.01

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $8.54 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $6.04 Billion
EBIT Earnings before tax and interest payments. $1.52 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. -$963 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -11.27%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -194.7%
Return on Equity Equity divided by market cap. 81.61%
Return on Assets Indicates a company's profitability in relation to its total assets. -3.56%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 6.64%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2023 Q2 2023 Q3 2023 Q4 2023

About Bausch Health Companies Inc

Employees: 21,100

Industry: Pharmaceutical Preparation Manufacturing

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

Similar stocks

Onconova Therapeutics Inc
Onconova Therapeutics Inc
Opko Health Inc
Opko Health Inc

News

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Bausch Health has a solid business model with steady revenue generation and strong operating income margins. Learn why I''m giving BHC stock a sell recommend...

Seeking Alpha Seeking Alpha, 4 days ago
Bausch Health Companies Inc.: CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy -Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to

Bausch Health Companies Inc.: CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy -Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to

This corrects and replaces the release that was disseminated earlier todayLack of OHE-specific diagnostic code in hospitals may increase risk of additional c...

Finanz Nachrichten Finanz Nachrichten, 23 days ago
Bausch Health Companies Inc.: As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder

Bausch Health Companies Inc.: As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder

Company Introduces Multimedia Resources to Bring Awareness of SADLAVAL, QC / ACCESSWIRE / November 8, 2023 / As daylight saving time concluded for much of th...

Finanz Nachrichten Finanz Nachrichten, 26 days ago
Earnings call: Bausch Health''s robust Q3 2023 performance, with focus on R&D and potential Bausch & Lomb separation

Earnings call: Bausch Health''s robust Q3 2023 performance, with focus on R&D and potential Bausch & Lomb separation

https://www.investing.com/news/stock-market-news/earnings-call-bausch-healths-robust-q3-2023-performance-with-focus-on-rd-and-potential-bausch--lomb-separati...

Investing.com Investing.com, about 1 month ago
Never miss a trade
To improve your user experience we use cookies.